Previous 10 | Next 10 |
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020 at 1:20 p.m. ET. Jamey Mock, SVP and chief financial officer of P...
PerkinElmer (PKI) have reached an agreement with Horizon Discovery Group (HZNQF) to acquire latter for ~$383M (£296M) in all cash offer.The transaction has a total enterprise value of ~$368M (£284M) and, is expected to close in Q1 2021. With this investment, PerkinElmer will expand ...
Addition of CRISPR and RNAi offerings to complement PerkinElmer's life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Horizon Disc...
The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: PerkinElmer, Inc. 2020 Q3 - Results - Earnings Call Presentation
PerkinElmer (PKI) announces emergency use authorization to allow sample pooling with its New Coronavirus Nucleic Acid Detection Kit, and help increase the number of individuals who can be tested without increasing resources.The real-time RT-PCR test intended for the qualitative detection...
Latest testing strategy to increase the sample processing efficiency PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer ® New Coro...
Image source: The Motley Fool. PerkinElmer Inc (NYSE: PKI) Q3 2020 Earnings Call Oct 28, 2020 , 5:00 p.m. ET Operator Continue reading For further details see: PerkinElmer Inc (PKI) Q3 2020 Earnings Call Transcript
PerkinElmer, Inc. (PKI) Q3 2020 Earnings Conference Call October 28, 2020 5 PM ET Company Participants Bryan Kipp - Vice President-Investor Relations Prahlad Singh - President and Chief Executive Officer Jamey Mock - Senior Vice President and Chief Financial Officer Conference Call Participan...
PerkinElmer (PKI): Q3 Non-GAAP EPS of $2.09 beats by $0.60; GAAP EPS of $1.57 beats by $0.32.Revenue of $964.03M (+36.4% Y/Y) beats by $126.87M.Press Release For further details see: PerkinElmer EPS beats by $0.60, beats on revenue
Revenue of $964.0 million; 36% reported growth; 34% organic growth GAAP EPS from continuing operations of $1.57; Adjusted EPS of $2.09 PerkinElmer, Inc . (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial resu...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...